封面
市場調查報告書
商品編碼
1866522

全球消化酵素市場:預測(2025-2030 年)

Global Digestive Enzymes Market - Forecasts from 2025 to 2030

出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 148 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球消化酵素市場規模預計將從 2025 年的 864,094,000 美元成長到 2030 年的 1,245,720,000 美元,複合年成長率為 7.59%。

由於胃腸道疾病和腹部疾病的增加,以及人們對預防醫學日益成長的興趣,全球消化酵素市場預計將迎來顯著成長。消化酵素是能夠將大分子分解成可吸收成分的複雜蛋白質,其最佳功能需要特定的pH值和溫度條件。這些酵素作為非處方補充劑出售,能夠有效緩解常見的消化器官系統問題,例如脹氣、腹脹、消化不良、胃灼熱和一般不適。飲食習慣的改變和人口老化是推動市場成長的主要因素,但來自益生菌和益生元等替代產品的競爭也對市場成長構成挑戰。

市場促進因素

胃腸道和腹部疾病發病率的上升是推動消化酵素補充劑市場成長的主要因素。為了緩解這些症狀並維持健康的消化功能,人們對消化酵素補充劑的需求日益成長。老年人口的成長,由於酵素分泌老齡化成長而減少,更容易出現消化器官系統問題,這進一步促進了市場擴張。此外,消費者對預防性健康管理意識的提高,也推動了消化酵素補充劑作為積極健康策略的一部分的需求。不健康的飲食習慣,例如食用加工食品和不規則的飲食,會加劇消化器官系統問題,從而增加了對酵素製劑的需求。

市場限制

益生菌和益生元等替代消化健康產品的存在對市場成長構成了挑戰,這些產品透過不同的機制促進腸道健康,並爭奪消費者的偏好,這可能會限制消化酵素補充劑在某些細分市場的普及。

目錄

第1章執行摘要

第2章 市場概覽

  • 市場概覽
  • 市場定義
  • 調查範圍
  • 市場區隔

第3章 商業情境

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 波特五力分析
  • 產業價值鏈分析
  • 政策與法規
  • 策略建議

第4章 技術展望

5. 全球消化酵素市場(按類型分類)

  • 介紹
  • 蛋白酶
  • 脂肪酶
  • 乳糖酶
  • 澱粉酶
  • 其他

6. 全球消化酵素市場(依來源分類)

  • 介紹
  • 動物源性
  • 植物來源
  • 微生物來源

7. 全球消化酵素市場(按應用領域分類)

  • 介紹
  • 運動營養
  • 嬰兒營養
  • 醫學營養
  • 其他

8. 全球消化酵素市場(按地區分類)

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 其他
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 印尼
    • 泰國
    • 其他

第9章 競爭格局與分析

  • 主要企業和策略分析
  • 市佔率分析
  • 併購、協議和合作
  • 競爭對手儀錶板

第10章:公司簡介

  • Enzymedica
  • Deerland Enzymes, Inc.(Archer Daniels Midland)
  • AST Enzymes
  • Onnit Labs, Inc
  • Metagenics
  • National Enzyme Company Inc.
  • Abbott Laboratories
  • Amway Corporation
  • Country Life, LLC
  • Biotics Research Corporation
  • Klaire Labs
  • Integrative Therapeutics LLC

第11章附錄

  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要收益
  • 調查方法
  • 簡稱
簡介目錄
Product Code: KSI061611927

The Digestive Enzymes Market is anticipated to climb from USD 864.094 million in 2025 to USD 1,245.720 million by 2030, with a 7.59% CAGR.

The global digestive enzymes market is poised for significant growth, driven by the increasing prevalence of gastrointestinal and abdominal disorders and a growing focus on preventive health management. Digestive enzymes, complex proteins that break down macromolecules into absorbable constituents, require specific pH and temperature conditions to function optimally. Available as commercial supplements, these enzymes effectively alleviate common digestive issues such as gas, bloating, indigestion, heartburn, and general discomfort. The market is propelled by shifts in dietary habits and an aging population, though competition from alternative products like probiotics and prebiotics presents challenges to growth.

Market Drivers

The rising incidence of gastrointestinal and abdominal disorders is a primary driver, as these conditions increase demand for digestive enzyme supplements to manage symptoms and support healthy digestion. The growing geriatric population, which is more prone to digestive issues due to age-related declines in enzyme production, further fuels market expansion. Additionally, increasing consumer awareness of preventive health management is driving demand for digestive enzyme supplements as part of proactive wellness strategies. The shift away from healthy eating habits, characterized by processed foods and irregular diets, exacerbates digestive issues, boosting the need for enzyme-based solutions.

Market Restraints

The availability of alternative digestive health products, such as probiotics and prebiotics, poses a challenge to market growth. These alternatives, which promote gut health through different mechanisms, compete for consumer preference and may limit the adoption of digestive enzyme supplements in certain segments.

Market Segmentation

While specific segmentation details are not provided, the digestive enzymes market likely includes categories such as product type (e.g., single-enzyme or multi-enzyme supplements), application (e.g., digestive disorder management, general wellness), and end-user (e.g., adults, geriatrics). Geographically, the market spans regions with high healthcare awareness, such as North America and Europe, with emerging markets in Asia-Pacific showing growth potential due to rising health consciousness and disposable incomes. The supplements are distributed through retail pharmacies, e-commerce platforms, and health food stores, catering to diverse consumer needs.

Key Players

Major companies in the digestive enzymes market include Enzymedica, Deerland Enzymes, Inc., AST Enzymes, Onnit Labs, Inc., Metagenics, National Enzyme Company Inc., Garden of Life Inc., Amway Corporation, and Country Life, LLC. These players are focusing on product innovation, such as developing targeted enzyme formulations, and expanding distribution channels to strengthen their market positions. Strategic partnerships and marketing efforts emphasizing preventive health are also key to their competitive strategies.

Market Insights

The market analysis highlights the growing demand for digestive enzyme supplements, driven by health trends and demographic shifts. The report likely incorporates data on sales trends, consumer preferences, and regulatory frameworks, providing a comprehensive view of market dynamics. The emphasis on preventive health and the rising burden of digestive disorders underscore the market's growth potential.

In conclusion, the digestive enzymes market is set for robust growth, driven by the increasing prevalence of gastrointestinal disorders, an aging population, and heightened health awareness. North America and Europe are key markets, with Asia-Pacific emerging due to rising consumer spending. However, competition from probiotics and prebiotics may temper growth. Leading companies are leveraging innovation and strategic marketing to capitalize on the demand for digestive health solutions, ensuring sustained market expansion.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation

By Type

  • Protease
  • Lipase
  • Lactase
  • Amylase
  • Others

By Source

  • Animal
  • Plant
  • Microbial

By Application

  • Sports Nutrition
  • Infant Nutrition
  • Medical Nutrition
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL DIGESTIVE ENZYMES MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Protease
  • 5.3. Lipase
  • 5.4. Lactase
  • 5.5. Amylase
  • 5.6. Others

6. GLOBAL DIGESTIVE ENZYMES MARKET BY SOURCE

  • 6.1. Introduction
  • 6.2. Animal
  • 6.3. Plant
  • 6.4. Microbial

7. GLOBAL DIGESTIVE ENZYMES MARKET BY APPLICATION

  • 7.1. Introduction
  • 7.2. Sports Nutrition
  • 7.3. Infant Nutrition
  • 7.4. Medical Nutrition
  • 7.5. Others

8. GLOBAL DIGESTIVE ENZYMES MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. USA
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. United Kingdom
    • 8.4.4. Spain
    • 8.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. Japan
    • 8.6.4. South Korea
    • 8.6.5. Indonesia
    • 8.6.6. Thailand
    • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Enzymedica
  • 10.2. Deerland Enzymes, Inc. (Archer Daniels Midland)
  • 10.3. AST Enzymes
  • 10.4. Onnit Labs, Inc
  • 10.5. Metagenics
  • 10.6. National Enzyme Company Inc.
  • 10.7. Abbott Laboratories
  • 10.8. Amway Corporation
  • 10.9. Country Life, LLC
  • 10.10. Biotics Research Corporation
  • 10.11. Klaire Labs
  • 10.12. Integrative Therapeutics LLC

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key benefits for the stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations